Persistent androgen receptor addiction in castration-resistant prostate cancer

por Schweizer, Michael T., Yu, Evan Y.
Publicado 2015

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond

por Schweizer, Michael T., Yu, Evan Y.
Publicado 2017

The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions

por Yu, Evan Y, Oh, William K
Publicado 2014

Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunoth...

por Cheng, Heather H., Soleau, Colleen, Yu, Evan Y.
Publicado 2015

Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate ca...

por Reed-Perino, Darien E, Lai, Michael, Yu, Evan Y, Schweizer, Michael T
Publicado 2023

Hormone levels following surgical and medical castration: defining optimal androgen suppression

por Schweizer, Michael T, Hancock, Michael L, Getzenberg, Robert H, Yu, Evan Y
Publicado 2018

Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies

por Graham, Laura S., Montgomery, Bruce, Cheng, Heather H., Yu, Evan Y., Nelson, Peter S., Pritchard, Colin, Erickson, Stephanie, Alva, Ajjai, Schweizer, Michael T.
Publicado 2020

Whole-Body [(18)F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687

por Muzi, Mark, O’Sullivan, Finbarr, Perk, Timothy G., Muzi, John P., Mankoff, David A., Jeraj, Robert, Duan, Fenghai, Yu, Evan Y.
Publicado 2021

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis

por Ghali, Fady, Zhao, Yibai, Patel, Devin, Jewell, Teresa, Yu, Evan Y., Grivas, Petros, Montgomery, R. Bruce, Gore, John L., Etzioni, Ruth B., Wright, Jonathan L.
Publicado 2022

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer

por Wong, Risa L., Duong, Mai T., Tangen, Catherine M., Agarwal, Neeraj, Cheng, Heather H., Vogelzang, Nicholas J., Hussain, Maha, Thompson, Ian M., Quinn, David I., Yu, Evan Y.
Publicado 2020

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

por Carlson, Alexander S., Acevedo, Rigo I., Lim, Daniel M., Gulati, Roman, Gawne, Agnes, Sokolova, Alexandra O., Cheng, Heather H., Nelson, Peter S., Montgomery, R. Bruce, Yu, Evan Y., Schweizer, Michael T.
Publicado 2020

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer

por Lee, Franklin C., Harris, William, Cheng, Heather H., Shenoi, Jaideep, Zhao, Song, Wang, Junfeng, Champion, Thomas, Izard, Jason, Gore, John L., Porter, Michael, Yu, Evan Y., Wright, Jonathan L.
Publicado 2013

Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T

por Madan, Ravi A, Antonarakis, Emmanuel S, Drake, Charles G, Fong, Lawrence, Yu, Evan Y, McNeel, Douglas G, Lin, Daniel W, Chang, Nancy N, Sheikh, Nadeem A, Gulley, James L
Publicado 2020

Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

por Jensen, Kendal, Konnick, Eric Q., Schweizer, Michael T., Sokolova, Alexandra O., Grivas, Petros, Cheng, Heather H., Klemfuss, Nola M., Beightol, Mallory, Yu, Evan Y., Nelson, Peter S., Montgomery, Bruce, Pritchard, Colin C.
Publicado 2020

Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate

por Schweizer, Michael T., Cheng, Heather H., Tretiakova, Maria S., Vakar-Lopez, Funda, Klemfuss, Nola, Konnick, Eric Q., Mostaghel, Elahe A., Nelson, Peter S., Yu, Evan Y., Montgomery, Bruce, True, Lawrence D., Pritchard, Colin C.
Publicado 2016

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

por Schweizer, Michael T., Haugk, Kathleen, McKiernan, Jožefa S., Gulati, Roman, Cheng, Heather H., Maes, Jessica L., Dumpit, Ruth F., Nelson, Peter S., Montgomery, Bruce, McCune, Jeannine S., Plymate, Stephen R., Yu, Evan Y.
Publicado 2018

Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

por Schweizer, Michael T., Haugk, Kathleen, McKiernan, Jožefa S., Gulati, Roman, Cheng, Heather H., Maes, Jessica L., Dumpit, Ruth F., Nelson, Peter S., Montgomery, Bruce, McCune, Jeannine S., Plymate, Stephen R., Yu, Evan Y.
Publicado 2018

Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies

por Dianatinasab, Mostafa, Wesselius, Anke, Salehi‐Abargouei, Amin, Yu, Evan Y. W., Fararouei, Mohammad, Brinkman, Maree, van den Brandt, Piet, White, Emily, Weiderpass, Elisabete, Le Calvez‐Kelm, Florence, Gunter, Marc J., Huybrechts, Inge, Zeegers, Maurice P.
Publicado 2022

Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer

por Cheng, Heather H., Sokolova, Alexandra O., Gulati, Roman, Bowen, Deborah, Knerr, Sarah A., Klemfuss, Nola, Grivas, Petros, Hsieh, Andrew, Lee, John K., Schweizer, Michael T., Yezefski, Todd, Zhou, Alicia, Yu, Evan Y., Nelson, Peter S., Montgomery, Bruce
Publicado 2023

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

por Mostaghel, Elahe A., Marck, Brett T., Kolokythas, Orpheus, Chew, Felix, Yu, Evan Y., Schweizer, Michael T., Cheng, Heather H., Kantoff, Phillip W., Balk, Steven P., Taplin, Mary-Ellen, Sharifi, Nima, Matsumoto, Alvin M., Nelson, Peter S., Montgomery, R. Bruce
Publicado 2021